Interim report of a phase I dose escalation of hypofractionated stereotactic radiotherapy as salvage therapy for persistent or recurrent glioma

被引:0
|
作者
Hudes, RS
Corn, BW
WernerWasik, M
Andrews, DW
Rosenstock, J
Curran, WJ
机构
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:713 / 713
页数:1
相关论文
共 50 条
  • [41] The Effect of Stereotactic Lung Radiotherapy on Pulmonary Function Tests in A Prospective Phase I/II Dose Escalation Study
    Tinger, Alfred
    Bures, Sergio
    Klares, Scott
    Goldberg, Jonathan
    Lester, Thomas
    Rummo, Nicholas
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (02): : 204 - 204
  • [42] Phase I trial of radiation dose escalation in patients with locally advanced hepatocellular carcinoma: An interim report
    Zhao, J.
    Ren, Z.
    Jiang, G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01): : S15 - S15
  • [43] Phase I feasibility and dose escalation multicenter trial of stereotactic body radiation therapy for liver metastases
    Schefter, TE
    Kavanagh, BD
    Timmerman, RD
    Cardenes, HR
    Gaspar, LE
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 352S - 352S
  • [44] A phase I/II trial of stereotactic body radiation therapy (SBRT) for lung metastases: Initial report of dose escalation and early toxicity
    Schefter, Tracey E.
    Kavanagh, Brian D.
    Raben, David
    Kane, Madeleine
    Chen, Changhu
    Stuhr, Kelly
    Kelly, Karen
    Mitchell, John D.
    Bunn, Paul A.
    Gaspar, Laurie E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (04): : S120 - S127
  • [45] Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas
    Minniti, Giuseppe
    Scaringi, Claudia
    De Sanctis, Vitaliana
    Lanzetta, Gaetano
    Falco, Teresa
    Di Stefano, Domenica
    Esposito, Vincenzo
    Enrici, Riccardo Maurizi
    JOURNAL OF NEURO-ONCOLOGY, 2013, 111 (02) : 187 - 194
  • [46] An interim analysis of a phase I dose escalation clinical trial on extracranial SBRT
    Deodato, F.
    Macchia, G.
    Cilla, S.
    Ianiro, A.
    Picardi, V.
    Ferro, M.
    Tolento, G.
    Siepe, G.
    Arcelli, A.
    Buwenge, M.
    Bisello, S.
    Maselli, G.
    Sallustio, G.
    Ciabatti, S.
    Frakulli, R.
    Cammelli, S.
    Frezza, G. P.
    Valentini, V.
    Morganti, A. G.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S242 - S242
  • [47] Hypofractionated stereotactic radiotherapy and continuous low-dose temozolomide in patients with recurrent or progressive malignant gliomas
    Giuseppe Minniti
    Claudia Scaringi
    Vitaliana De Sanctis
    Gaetano Lanzetta
    Teresa Falco
    Domenica Di Stefano
    Vincenzo esposito
    Riccardo Maurizi Enrici
    Journal of Neuro-Oncology, 2013, 111 : 187 - 194
  • [48] Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors
    Le, Quynh-Thu
    Loo, Billy W.
    Ho, Anthony
    Cotrutz, Christian
    Koong, Albert C.
    Wakelee, Heather
    Kee, Stephen T.
    Constantinescu, Dana
    Whyte, Richard I.
    Donington, Jessica
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (08) : 802 - 809
  • [49] Phase I Dose-Escalation Study of Stereotactic Body Radiotherapy Boost for Cervical Cancer Unsuitable for Intracavitary Brachytherapy
    Ito, K.
    Kito, S.
    Shimizuguchi, T.
    Ogawa, H.
    Tanaka, H.
    Nihei, K.
    Karasawa, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E323 - E323
  • [50] Salvage stereotactic body radiotherapy in radio-recurrent prostate cancer - what dose is feasible?
    Tree, A. C.
    Khoo, V. S.
    Van As, N. J.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S690 - S690